Progression of cortical thinning in early Parkinson's disease

Movement Disorders

Volumn 27, Issue 14, 2012, Pages 1746-1753

  Ibarretxe Bilbao, Naroa ^a,b,c,d   Junque, Carme ^a,b,c   Segura, Barbara ^a,b,c   Baggio, Hugo C ^a,b,c   Marti, Maria J ^a,b   Valldeoriola, Francesc ^a,b   Bargallo, Nuria ^a,b   Tolosa, Eduardo ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY OF DEUSTO   (Spain)

Author keywords

Cognition; Cortical thickness; Longitudinal; Parkinson's disease

Indexed keywords

LEVODOPA;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN ATROPHY; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); CORTICAL THINNING; DISEASE DURATION; FEMALE; FOLLOW UP; FRONTOTEMPORAL REGION; GRAY MATTER; HUMAN; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NERVOUS SYSTEM PARAMETERS; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; REY AUDITORY VERBAL LEARNING TEST; VOXEL BASED MORPHOMETRY; WECHSLER INTELLIGENCE SCALE;

AGED; ATROPHY; CEREBRAL CORTEX; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 84871724455     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25240     Document Type: Article

References (61)

1. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004; 127: 550-560.
2. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005; 65: 1239-1245.
3. Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G, Norwegian ParkWest Study Group. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology 2009; 72: 1121-1126.
4. Elgh E, Domellof M, Linder J, Edstrom M, Stenlund H, Forsgren L. Cognitive function in early Parkinson's disease: a population-based study. Eur J Neurol 2009; 16: 1278-1284.
5. Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007; 130: 1787-1798.
6. Muslimovic D, Post B, Speelman JD, De Haan RJ, Schmand B. Cognitive decline in Parkinson's disease: a prospective longitudinal study. J Int Neuropsychol Soc 2009; 15: 426-437.
7. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
8. Jubault T, Brambati SM, Degroot C, et al. Regional brain stem atrophy in idiopathic Parkinson's disease detected by anatomical MRI. PLoS One 2009; 4: e8247.
9. Tinaz S, Courtney MG, Stern CE. Focal cortical and subcortical atrophy in early Parkinson's disease. Mov Disord 2011; 26: 436-441.
10. Ibarretxe-Bilbao N, Junqué C, Tolosa E, et al. Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease. Eur J Neurosci 2009; 30: 1162-1171.
11. Jubault T, Gagnon JF, Karama S, et al. Patterns of cortical thickness and surface area in early Parkinson's disease. Neuroimage 2011; 55: 462-467.
12. Ibarretxe-Bilbao N, Junqué C, Marti MJ, Tolosa E. Brain structural MRI correlates of cognitive dysfunctions in Parkinson's disease. J Neurol Sci 2011; 310: 70-74.
13. Beyer MK, Janvin CC, Larsen JP, Aarsland D. A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry 2007; 78: 254-259.
14. Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA. Parkinson's disease is associated with hippocampal atrophy. Mov Disord 2003; 18: 784-790.
15. Junqué C, Ramírez-Ruiz B, Tolosa E, et al. Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia. Mov Disord 2005; 20: 540-544.
16. Weintraub D, Doshi J, Koka D, et al. Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol 201; 68: 1562-1568.
17. Pereira JB, Junqué C, Martí MJ, Ramírez-Ruiz B, Bargalló N, Tolosa E. Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease. Mov Disord 2009; 24: 1193-1199.
18. Pereira JB, Junqué C, Martí MJ, Ramírez-Ruiz B, Bartrés-Faz D, Tolosa E. Structural brain correlates of verbal fluency in Parkinson's disease. Neuroreport 2009; 20: 741-744.
19. Hutton C, Draganski B, Ashburner J, Weiskopf N. A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging. Neuroimage 2009; 48: 371-380.
20. Winkler AM, Kochunov P, Blangero J, et al. Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. Neuroimage 2010; 53: 1135-1146.
21. Labate A, Cerasa A, Mula M, et al. Neuroanatomic correlates of psychogenic nonepileptic seizures: a cortical thickness and VBM study. Epilepsia 2012; 53: 377-385.
22. Palaniyappan L, Liddle PF. Dissociable morphometric differences of the inferior parietal lobule in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2012 [published online ahead of print March 28 2012].
23. Camicioli R, Sabino J, Gee M, et al. Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia. Mov Disord 2011; 26: 1443-1450.
24. Lewis MM, Smith AB, Styner M, et al. Asymmetrical lateral ventricular enlargement in Parkinson's disease. Eur J Neurol 2009; 16: 475-481.
25. Hu MT, White SJ, Chaudhuri KR, Morris RG, Bydder GM, Brooks DJ. Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline. J Neural Transm 2001; 108: 571-580.
26. Ramírez-Ruiz B, Martí MJ, Tolosa E, et al. Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J Neurol 2005; 252: 1345-1352.
27. Ibarretxe-Bilbao N, Ramírez-Ruiz B, Junqué C, et al. Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations. J Neurol Neurosurg Psychiatry 2010; 81: 650-657.
28. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 2006; 129: 1040-1049.
29. Daniel SE, Lees AJ. Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 1993; 39: 165-172.
30. Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 2007; 22: 2314-2324.
31. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation, 1996.
32. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-2314.
33. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 2000; 97: 11050-11055.
34. Segonne F, Dale AM, Busa E, et al. A hybrid approach to the skull stripping problem in MRI. Neuroimage 2004; 22: 1060-1075.
35. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 1998; 17: 87-97.
36. Fischl B, Liu A, Dale AM. Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging 2001; 20: 70-80.
37. Ségonne F, Pacheco J, Fischl B. Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE Trans Med Imaging 2007; 26: 518-529.
38. Reuter M, Fischl B. Avoiding asymmetry-induced bias in longitudinal image processing. Neuroimage 2011; 57: 19-21.
39. Reuter M, Rosas HD, Fischl B. Highly accurate inverse consistent registration: a robust approach. Neuroimage 2010; 53: 1181-1196.
40. Reuter M, Schmansky NJ, Rosas HD, Fischl B. Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage 2012; 61: 1402-1418.
41. Forman SD, Cohen JD, Fitzgerald M, Eddy WF, Mintun MA, Noll DC. Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold. Magn Reson Med 1995; 33: 636-647.
42. Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002; 33: 341-355.
43. Ashburner J, Friston KJ. Unified segmentation. Neuroimage 2005; 26: 839-851.
44. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007; 38: 95-113.
45. Asami T, Bouix S, Whitford TJ, Shenton ME, Salisbury DF, McCarley RW. Longitudinal loss of gray matter volume in patients with first-episode schizophrenia: DARTEL automated analysis and ROI validation. Neuroimage 2012; 59: 986-996.
46. Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC. A unified statistical approach for determining significant signals in images of cerebral activation. Human Brain Mapping 1996; 4: 58-73.
47. Ibarretxe-Bilbao N, Ramírez-Ruiz B, Tolosa E, et al. Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia. J Neurol 2008; 255: 1324-1331.
48. Levy G. The relationship of Parkinson disease with aging. Archives of Neurology 2007; 64: 1242-1246.
49. Fields JA, Ferman TJ, Boeve BF, Smith GE. Neuropsychological assessment of patients with dementing illness. Nat Rev Neurol 2011; 7: 677-687.
50. Williams-Gray CH, Evans JR, Goris A, et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 2009; 132: 2958-2969.
51. Compta Y, Parkkinen L, O'Sullivan SS, et al. Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? Brain 2011; 134: 1493-1505.
52. Castner SA, Williams GV, Goldman-Rakic PS. Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. Science 2000; 287: 2020-2022.
53. Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev 2006; 30: 1-23.
54. Fallon SJ, Williams-Gray CH, Barker RA, Owen AM, Hampshire A. Prefrontal dopamine levels determine the balance between cognitive stability and flexibility. Cereb Cortex 2012 [published online ahead of print February 20 2012].
55. Rihet P, Possamaï CA, Micallef-Roll J, Blin O, Hasbroucq T. Dopamine and human information processing: a reaction-time analysis of the effect of levodopa in healthy subjects. Psychopharmacology (Berl) 2002; 163: 62-67.
56. Cerasa A, Messina D, Pugliese P, et al. Increased prefrontal volume in PD with levodopa-induced dyskinesias: a voxel-based morphometry study. Mov Disord 2011; 26: 807-812.
57. Ashburner J, Friston KJ. Voxel-based morphometry--the methods. Neuroimage 2000; 11: 805-821.
58. Worsley KJ, Andermann M, Koulis T, MacDonald D, Evans AC. Detecting changes in nonisotropic images. Hum Brain Mapp 1999; 8: 98-101.
59. Salimi-Khorshidi G, Smith SM, Nichols TE. Adjusting the effect of nonstationarity in cluster-based and TFCE inference. Neuroimage 2011; 54: 2006-2019.
60. Hayasaka S, Nichols TE. Validating cluster size inference: random field and permutation methods. Neuroimage 2003; 20: 2343-2356.
61. Hayasaka S, Phan KL, Liberzon I, Worsley KJ, Nichols TE. Nonstationary cluster-size inference with random field and permutation methods. Neuroimage 2004; 22: 676-687.